Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
Posts
- Category: Articles (continued)
- Altered brain mechanisms of emotion processing in pre-manifest Huntington’s disease
- Alzheimer's breakthrough hailed as 'turning point'
- Amendment to the RG6042 Phase III GENERATION HD1 study design
- An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin
- An intellectually active lifestyle protects against neurodegeneration in people with Huntington's disease
- An open approach to Huntington’s disease research
- Animal study points to a treatment for Huntington's disease
- Announcement of 2CARE Early Study Closure
- Anonymous donors, confidentiality, and how we all must work to defeat Huntington’s disease
- Anticipated Approval of Three New Therapies Through 2023 Will Expand Treatment Options for the Control and Relief of Motor Symptoms in Huntington's Disease
- Antisense Oligoneucleotide Corrects Striatal Transcriptional Abnormalities and Protects Function in HD Mice
- Are HD Clinical Trials Measuring the Right Outcome Measure?
- Are Long-Range Structural Correlations Behind the Aggregration Phenomena of Polyglutamine Diseases?
- As range of possible therapies grows, CHDI expands efforts to defeat Huntington’s disease
- ASO gene silencing reaches further, lasts longer
- Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells
- At last, hope for families living in the shadow of Huntington’s disease
- At Therapeutics Conference, landmark study of young gene carriers highlights how Huntington’s disease researchers seek to solve critical puzzles
- Auspex Announces Positive Topline Results From Registration Trial of SD-809 for Chorea Associated With Huntington's Disease
- Auspex Appoints Pratik Shah as CEO and Expands Executive Team
- Auspex Initiates Phase 3 Trial of SD-809 in Huntington's Disease
- Auspex Pharmaceuticals Initiates Second Pivotal Clinical Trial for SD-809 in Tardive Dyskinesia
- Auspex Pharmaceuticals Receives FDA Orphan Drug Designation of SD-809 for Treatment of Huntington's Disease
- Ban on genetic test results for insurance renewed by industry
- BARCELLONA 19 - 21 SETTEMBRE: 8° MEETING PLENARIO DEL NETWORK EUROPEO PER LA MALATTIA DI HUNTINGTON – NOVITA’ E PROSPETTIVE
- Bee Brain Plasticity: Turning Back the Clock on Aging
- Behind the Scenes at EHDN
- Benitec Biopharma cross-licenses with uniQure to treat Huntington's and Hepatitis B
- Berkeley Lab Scientists Help Develop Promising Therapy for Huntington’s Disease
- BIG PHARMA BUYS INTO CROWDSOURCING FOR DRUG DISCOVERY
- biOasis Delivers siRNA to the Brain Using its Transcend Peptide Vector
- BioSensics™ Has Received over $2.5M in Grant Funding from the NIH to Develop a Novel Telecare Solution for Huntington’s Disease
- Blood test for monitoring Huntington’s disease may be possible in future
- Brain Development Is Guided by Junk DNA that Isn’t Really Junk
- Brain disorder study helps cure bid
- Breakthrough for Huntington's
- Breakthrough program halts Huntington’s progression
- BU researchers identify possible biomarker for Huntington's disease
- Buck Scientists Correct Huntington's Disease Mutation in Induced Pluripotent Stem Cells
- C-Path and CHDI launch consortium to accelerate development of Huntington’s disease therapies
- C-Path, CHDI, and CDISC Announce Public Review for Huntington’s Disease Therapeutic Area User Guide
- California stem cell agency approves $19 million clinical trial project as Huntington’s disease families ‘change the course of science’
- CAMBRIDGE TECHNOLOGY TARGETS HUNTINGTON’S DISEASE
- Can CRISPR Conquer Huntington’s?
- Can’t attend the 27th Annual HDSA Convention? Then HDSA will bring the Convention to You
- CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE SCIENTISTS DEVELOP THERAPEUTIC PROTEIN, PROTECT NERVE CELLS FROM HUNTINGTON’S DISEASE
- Cassidy, Gillibrand Improve Access to Care for Huntington’s Disease Patients
- Cattaneo: «Basta abusare della speranza di chi soffre»
- Cell Contents May be Key to Controlling Toxicity of Huntington’s Disease Protein
- Cell Loss in the Brain Relates to Variations in Individual Symptoms in Huntington’s Disease
Plugin by dagondesign.com
